SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹1,870 Cr | ₹2,846 Cr | ₹6,198 Cr | ₹931 Cr | ₹3,869 Cr |
What is the latest Total Debt ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹1,870 Cr |
| Mar2024 | ₹2,846 Cr |
| Mar2023 | ₹6,198 Cr |
| Mar2022 | ₹931 Cr |
| Mar2021 | ₹3,869 Cr |
How is Total Debt of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,870 Cr | -34.30 | |
| Mar2024 | ₹2,846 Cr | -54.09 | |
| Mar2023 | ₹6,198 Cr | 565.94 | |
| Mar2022 | ₹931 Cr | -75.94 | |
| Mar2021 | ₹3,869 Cr | - | |
Compare Total Debt of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,771.2 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
| MANKIND PHARMA | ₹91,867.7 Cr | -2.4% | 3.2% | -3.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% |
4.7% |
6.2% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses